Get Your Story Straight: Patent Office Cracks Down on Inconsistent Statements Made Before the FDA
While it may not seem controversial to promote honesty before the USPTO, a recent Federal Register Notice goes far beyond requiring candor.
pharamaceuticals
-
Read more: Get Your Story Straight: Patent Office Cracks Down on Inconsistent Statements Made Before the FDA -
Read more: How Policies Enacted During COVID-19 Might Reduce Future Drug Spending How Policies Enacted During COVID-19 Might Reduce Future Drug Spending
A positive outcome of the pandemic may be the demonstration via emergency measures that state governments can be flexible in substitution policies.
-
Read more: New Podcast Tackles Drug Pricing, Market Power, and More New Podcast Tackles Drug Pricing, Market Power, and More
“Deep Dive” is broader than just pharmaceutical policy, and will explore market failures in health care, criminal justice, education, and public finance, including how to fix them.
